Kenvue to present Phase III findings on minoxidil foam regrowth at EADV Congress

Kenvue said new clinical and preclinical findings are slated for presentation at the EADV Congress in Vienna from Sept. 30 to Oct. 3, 2026, including analysis linking earlier 5% minoxidil foam use to higher hair regrowth in men with androgenetic alopecia.